Tirzepatide is a medication for the treatment of type 2 diabetes. It belongs to a class of drugs
called dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP)
receptor agonists.
Tirzepatide works by targeting both the GIP and GLP-1 receptors, which helps to regulate blood
sugar levels in multiple ways, including stimulating insulin release, reducing glucagon secretion,
slowing gastric emptying and promoting weight loss.
Clinical trials have shown promising results with Tirzepatide in improving glycemic control, reducing
body weight, and potentially lowering cardiovascular risk factors in people with type 2 diabetes. It is
administered via subcutaneous injection.
Tirzepatide injections are the first of their kind for the treatment of diabetes and work very well for
weight loss. Tirzepatide helps you lose weight in a few ways. It signals your brain and tells it you are
full, so you eat less. It also slows how fast food moves through your stomach, so you feel full longer.